The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durability of responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2 (HD IL-2).
 
Joseph Clark
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer; Prometheus
Consulting or Advisory Role - Novartis; Prometheus
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis; Pfizer; Prometheus
Research Funding - Argos Therapeutics (Inst); Bristol-Myers Squibb (Inst); Prometheus (Inst)
 
Michael A. Morse
Stock and Other Ownership Interests - PhytoChem
Honoraria - Bayer; Bristol-Myers Squibb; Celgene; Genentech; Merrimack; Novartis; Onyx; Prometheus; Sanofi; Taiho Pharmaceutical
Consulting or Advisory Role - Genentech; Merrimack; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Genentech; Novartis; Prometheus
Research Funding - Aduro Biotech; AlphaVax; Onyx; Prometheus
 
Michael K.K. Wong
No Relationships to Disclose
 
David F. McDermott
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Merck; Pfizer
Research Funding - Prometheus
 
Howard Kaufman
Consulting or Advisory Role - Alkermes; Amgen; Merck; Merck Serono; Prometheus
Research Funding - Bristol-Myers Squibb/Medarex
 
Gregory A. Daniels
Patents, Royalties, Other Intellectual Property - UC San Diego (Inst)
Other Relationship - Prometheus
 
Jessica C Perritt
Employment - Prometheus
 
Hong Hua
Employment - Prometheus
 
Sandra Aung
Employment - Prometheus
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; Merck; Roche Pharma AG
Patents, Royalties, Other Intellectual Property - UbiVac